Menu

Smartphone Diagnostic

Researchers design a device that attaches to a smartphone to test for diverse infectious diseases from a drop of blood.

Feb 5, 2015
Jef Akst

A smartphone dongle with a disposable microfluidic cassetteTASSANEEWAN LAKSANASOPINA push of a button vacuums up a drop of blood from a finger prick, and in just 15 minutes, the device can determine if a person is infected with any of a variety of infectious diseases. The new device, developed by Columbia University’s Samuel Sia and colleagues, is designed to be hooked up to a smartphone, which provides a power source and a display for the results. Published yesterday (February 4) in Science Translational Medicine, the technology is the latest effort in smartphone diagnostics, which could bring improved health care to underdeveloped parts of the world.

The new device, which costs just $34, functions by drawing the blood sample through tiny channels containing “detection zones” designed to find antibodies in the blood suggestive of a particular pathogen’s presence. In a field test held at three Rwandan community clinics, health care workers screened patients for HIV and syphilis with 96-percent accuracy. The team is now planning a larger trial, Science reported.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.